We observed a significant increase in patient survival when Notch3 expression was strong in tumor cells (Fig. 1E), whereas stromal expression had no impact on survival (Fig. 1E), arguing in favor of a tumor cell-intrinsic role for Notch3 in breast cancers. This evidence concerns the gene NOTCH3 and breast carcinoma.